Screening for top U.S. stock prospects in 2018
30 stocks to buy for both growth and value
Advertisement
30 stocks to buy for both growth and value
What a rally it’s been. In calendar 2017, the S&P 500 Total Return index produced a whopping 21.8 per cent return with positive gains in all sectors except Energy and Telecommunications. Even though the US market has looked overvalued for multiple years, US equities continue to provide spectacular returns to investors.
For investors bullish on the US economy, the following growth-oriented strategy may offer some ideas. To develop this strategy, I used Morningstar CPMS to first rank stocks in the S&P 500 index on the following factors:
To qualify for purchase, a company’s Debt to Equity ratio must be in line or lower than the median of the sector to which it belongs and the stock must be ranked in the top 25% of stocks in the index based on the above five factors.
What we found
I used Morningstar CPMS to back test this strategy from April 2004, to December 2017. During this process, 20 stocks were purchased and equally weighted with a maximum of four stocks per economic sector. Once a month, we sell any stocks that rank below the top 35% of the S&P500 based on the above factors or if the company missed earnings expectations by more than 5%. When this happened, we would sell the stock and replace it with the highest ranked stock not already in our portfolio. Over this period, the strategy produced an annualized total return of 12.8% while the S&P 500 Total Return Index produced 8.9%. In calendar year 2017, this strategy produced a 29.9% return.
The below table shows a clear picture of how such a strategy performed in trailing periods:
Additionally, the return distribution of the portfolio are shown here:
The stocks that qualify for purchase into the strategy today are listed in the table below. As always, it is advised that investors conduct their own independent research before buying or selling any security.
Rank | Symbol | Company | Morningstar Sector | Market Cap ($USD Millions) | Return on Invested Capital (%) | 5Y EPS Growth Rate (%) | 3M Estimate Revision (%) | Enterprise Value/EBITDA | Debt to Equity Relative to Sector Median* | Price Change from Month End 9 Months Ago (%) | Price change from Month End 3 Months Ago (%) | Latest Earnings Surprise (%) | Dividend Yield (%) | Close Price as of January 18th, 2018 ($USD/Share) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | MU | Micron Technology Inc | Technology | 50908.73 | 29.49 | 113.18 | 33.81 | 4.23 | 0.65 | 58.98 | -0.72 | 8.52 | 0 | 43.99 |
2 | KORS | Michael Kors Holding | Consumer Cyclical | 9886.63 | 38.24 | 17.56 | 9.32 | 9.36 | 0 | 74.15 | 33.19 | 20.06 | 0 | 65.01 |
3 | ROST | Ross Stores Inc | Consumer Cyclical | 31202.22 | 46.52 | 12.94 | 2.59 | 13.81 | 0.17 | 25.62 | 28.6 | 3.9 | 0.78 | 81.65 |
4 | NVDA | NVIDIA Corporation | Technology | 134664 | 40.19 | 60.55 | 19.23 | 45.9 | 0.62 | 115.19 | 8.52 | 14.47 | 0.27 | 224.44 |
5 | TGT | Target Corporation | Consumer Defensive | 42344.3 | 11.19 | 5.94 | 22.67 | 7.67 | 1.05 | 39.48 | 31.94 | 3.69 | 3.18 | 77.9 |
6 | TXN | Texas Instruments Inc | Technology | 114729.12 | 32.11 | 22.98 | 0.11 | 16.56 | 0.56 | 47.02 | 20.4 | 5.47 | 2.13 | 116.41 |
7 | BIIB | Biogen | Healthcare | 72841.1 | 26.46 | 31.1 | 1.12 | 10.68 | 0.79 | 27 | 10.52 | 3.63 | 0 | 344.44 |
8 | LRCX | Lam Research Corp | Technology | 33271.85 | 25.36 | 50.49 | 0.9 | 13.47 | 0.49 | 41.84 | -1.5 | 2.04 | 0.97 | 205.45 |
9 | LUV | Southwest Airlines Co | Industrials | 38605.79 | 13.13 | 56.41 | 5.49 | 9.03 | 0.43 | 15.72 | 20.79 | 1.04 | 0.77 | 65.06 |
10 | TSCO | Tractor Supply Co | Consumer Cyclical | 10158.16 | 21.03 | 12.51 | 3.67 | 12.88 | 0.46 | 30.67 | 34.25 | 2.04 | 1.34 | 80.9 |
11 | GPS | Gap Inc | Consumer Cyclical | 13127.81 | 19.9 | -5.69 | 3.26 | 7.29 | 0.5 | 28.86 | 29.9 | 3.46 | 2.73 | 33.76 |
12 | PAYX | Paychex Inc | Industrials | 24751.47 | 40.61 | 9.02 | 0.21 | 17.3 | 0 | 16.24 | 8.03 | 0.36 | 2.9 | 68.91 |
13 | AMG | Affiliated Managers Grp | Financial Services | 11412.08 | 15.91 | 10.38 | 4.57 | 8.48 | 0.83 | 23.99 | 10.09 | 0.5 | 0.39 | 205.32 |
14 | HUM | Humana Inc | Healthcare | 39920.83 | 22.52 | 6.69 | 0.2 | 9.71 | 0.61 | 25.89 | 9.43 | 2.51 | 0.57 | 279.44 |
15 | CBG | CBRE Group, Inc. | Real Estate | 15340.16 | 12.54 | 18.68 | 4.35 | 10.18 | 0.7 | 26.19 | 14.93 | 5.79 | 0 | 45.19 |
16 | VLO | Valero Energy Corp | Energy | 42209.1 | 6.28 | -2.76 | 13.31 | 8.8 | 0.72 | 49.3 | 22.27 | 1.55 | 2.9 | 96.46 |
17 | EXPD | Expeditors Intl of Wash | Industrials | 11744.38 | 26.61 | 10.39 | 3.14 | 16.08 | 0 | 17.83 | 13.21 | 3.67 | 1.27 | 66.09 |
18 | CHRW | CH Robinson Worldwide | Industrials | 13059.49 | 17.92 | 7.48 | 9.03 | 17.05 | 0.73 | 28.86 | 19.29 | 0.07 | 1.96 | 93.68 |
19 | AET | Aetna Inc | Healthcare | 60488.29 | 11.89 | 12.73 | 0.99 | 10.54 | 0.89 | 37.33 | 9.09 | 5.32 | 1.08 | 185.49 |
20 | ALGN | Align Technology Inc | Healthcare | 21704.1 | 30.23 | 19.61 | 2.31 | 63.65 | 0 | 101.08 | 13.27 | 8.22 | 0 | 270.7 |
*Note that a figure of 0.65 in this column implies that the company’s Debt/Equity Ratio is 35% lower than the median of the sector.
Data as of January 18th, 2018
Source: Morningstar CPMS
More about Morningstar
Ian Tam, CFA, is an analyst with Morningstar Research Inc., which provides independent investment research in North America, Europe, Australia and Asia. Its research tool, Morningstar CPMS, provides quantitative North American equity research and portfolio analysis to institutional clients and financial advisers. CPMS data cover more than 95 per cent of the investable North American stock market. With more than 110 equity and credit analysts, Morningstar has one of the largest independent institutional equity research teams in the world.
Share this article Share on Facebook Share on Twitter Share on Linkedin Share on Reddit Share on Email